Zimbabwe has declined a significant American health deal valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' request for confidential biological samples.
The decision became public after a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesperson has since explained that the United States was seeking genetic material for scientific study and commercial gain but was not willing to share the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for further negotiations to reach a deal suitable to all parties so the country's vital HIV treatment initiative can proceed.
Wider Background
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a court suspended a similar health funding agreement after concerns were raised about the security of citizens' medical information.
After resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government agreements to boost openness and responsibility.
As per reports, Sixteen nations in Africa have so far signed these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to provide its genetic material and health information indefinitely, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"In essence, our nation would supply the basic resources for medical research with no assurance that the end products would be available to our citizens if a future health crisis arise."
National Interest and Global Health
He also noted that the American exit from the global health body and its pursuit of one-on-one deals were disrupting systems already established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This mechanism is intended to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how subsequent collaboration might be structured in a way that respects the sovereignty and interests of both nations."
Health Experts Reaction
Medical experts expressed it recognised the government's concerns, but urged that negotiations should continue since much of the nation's HIV programmes were funded by external financing.
"If specific concerns arise, including those relating to information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group commented.
This impasse highlights the continuing challenges between receiving vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.